Clinical Trial News and Research

RSS

First-in-class drug could prevent sepsis-related organ failure and death

A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels.

8 May 2024

Brain-computer interface translates ALS patient's brain activity into spoken words

Researchers successfully used a brain-computer interface to synthesize speech directly from brain activity in an ALS patient, achieving 80% word recognition accuracy by listeners, showcasing the interface's potential for aiding communication in severe speech impairments.

8 May 2024

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss.

8 May 2024

Novel head-mounted device shows promise in alleviating depression symptoms

A head-mounted device that generates an ultra-low frequency ultralow magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder.

8 May 2024

MS Australia urges government action on neurological research funding

MS Australia has welcomed the Government's pledge to invest in health and medical research but is concerned that not enough attention or funding is being dedicated to neurological research.

8 May 2024

AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.

7 May 2024

Breakthrough implantable cardiac pump offers hope for children awaiting heart transplants

A small, implantable cardiac pump that could help children await heart transplants at home, not in the hospital, has performed well in the first stage of human testing.

7 May 2024

Mobile teams boost immunization rates in rural Sierra Leone

COVID-19 vaccination rates remain low in many African countries, often because providing access to vaccines is difficult in remote areas.

7 May 2024

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.

7 May 2024

New diagnostic and treatment approach could revolutionize bladder cancer care

A new diagnostic and treatment approach for bladder cancer will undergo a clinical trial in Queensland.

6 May 2024

Mindfulness training reduces dropout rates and relapses in opioid addiction treatment

Supplementing standard opioid addiction treatment with Mindfulness Oriented Recovery Enhancement (MORE) -; an intervention that incorporates mindfulness training, savoring skills, and cognitive reappraisal -; cuts program dropout rates by 59 percent and relapses by 42 percent, according to Rutgers-led research.

6 May 2024

CRISPR-based gene editing shows promise in treating rare form of blindness

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.

6 May 2024

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

6 May 2024

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

6 May 2024

Study sheds light on the promising role of virtual reality in treating depression

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

6 May 2024

Plant-based medication may be an effective therapy to help people quit vaping

Eleven million U.S. adults use e-cigarettes to vape nicotine, and about half of them say that they want to stop, but many have trouble doing so because nicotine is an addictive drug.

6 May 2024

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Researchers from the Research Area on Neurological Diseases, Neuroscience, and Mental Health at the Sant Pau Research Institute, led by Dr. Juan Fortea, Director of the Memory Unit of the Neurology Service at the same hospital, have found that over 95% of individuals over 65 years old who have two copies of the APOE4 gene -APOE4 homozygotes- show biological characteristics of Alzheimer's pathology in the brain or biomarkers of this disease in cerebrospinal fluid and PET scans.

6 May 2024

Durable lymph-node expansion improves vaccine responses against tumors

1
2
3
4
...
1056
Next

Clinical Trial News and Research

First-in-class drug could prevent sepsis-related organ failure and death

Brain-computer interface translates ALS patient's brain activity into spoken words

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

Novel head-mounted device shows promise in alleviating depression symptoms

MS Australia urges government action on neurological research funding

AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

Breakthrough implantable cardiac pump offers hope for children awaiting heart transplants

Mobile teams boost immunization rates in rural Sierra Leone

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

New diagnostic and treatment approach could revolutionize bladder cancer care

Mindfulness training reduces dropout rates and relapses in opioid addiction treatment

CRISPR-based gene editing shows promise in treating rare form of blindness

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Study sheds light on the promising role of virtual reality in treating depression

Plant-based medication may be an effective therapy to help people quit vaping

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Durable lymph-node expansion improves vaccine responses against tumors

Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trials

NK cells' role in cancer therapy resistance unveiled

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News